Literature DB >> 3360048

The effect of food on the absorption of slow-release isosorbide-5-mononitrate tablets.

A H Thomson1, S H Miller, S T Green, B Whiting.   

Abstract

The influence of food on the absorption characteristics of slow release isosorbide-5-mononitrate tablets was investigated in 10 normal healthy volunteers. There were no differences in the peak concentration achieved or the area under the curve, but the peak concentration occurred later when the drug was administered after food. The apparent elimination half-life ranged from 4.7 to 10.1 h. Bioavailability of slow-release isosorbide-5-mononitrate is therefore unaffected by food, but there is a slower rate of absorption.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360048     DOI: 10.1007/bf01061416

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Gas-liquid chromatographic determination of isosorbide-5-mononitrate derivatized with perfluorinated anhydrides for pharmacokinetic and bioavailability investigations.

Authors:  A Marzo; E Treffner
Journal:  J Chromatogr       Date:  1985-12-13

2.  [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].

Authors:  H Mannebach; H Ohlmeier; E von Möllendorff; U Gleichmann; U Abshagen
Journal:  Med Welt       Date:  1981-04-07

3.  First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.

Authors:  U Abshagen; S Spörl-Radun
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Isosorbide 5-mononitrate pharmacokinetics in humans.

Authors:  T Taylor; L F Chasseaud; R Major; E Doyle; A Darragh
Journal:  Biopharm Drug Dispos       Date:  1981 Jul-Sep       Impact factor: 1.627

5.  Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.

Authors:  P Straehl; R L Galeazzi; M Soliva
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

6.  Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.

Authors:  U Abshagen; G Betzien; R Endele; B Kaufmann
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  6 in total
  2 in total

Review 1.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 2.  Long-acting isosorbide mononitrate.

Authors:  A Prakash; A Markham
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.